- cafead Apr 03, 2024 at 11:12: AM
via Novel therapies, often with expensive price tags and finite patient populations, require strategic new positioning if they are to have maximum positive impact. Here, Alpharmaxim’s William Hind explains the science of behavioral change and how, applied as an integral part of medical communications, it could help deliver important new drugs to those who need them.
article source
article source